phjacoby/ETL_Datamanagement
1
1
Fork 0
Code Issues Pull Requests Actions Packages Projects Releases Wiki Activity

init

Browse Source
This commit is contained in:
Philipp Jacoby
2026-01-10 16:18:54 +01:00
commit 2384a33be2
25 changed files with 2338904 additions and 0 deletions
Download Patch File Download Diff File Expand all files Collapse all files

346
neo4j_csv/nodes_Pharmacologic_Class.csv Normal file
View File

@@ -0,0 +1,346 @@
id,name,source,license,url,description,chromosome,inchikey,inchi,mesh_id,bto_id,class_type
N0000007632,Thyroxine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007632,,,,,,,Chemical/Ingredient
N0000011272,Thiazolidinediones,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011272,,,,,,,Chemical/Ingredient
N0000178477,Decreased Blood Pressure,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000178477,,,,,,,Physiologic Effect
N0000010288,Osmotic Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000010288,,,,,,,Mechanism of Action
N0000190114,Cytochrome P450 3A Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190114,,,,,,,Mechanism of Action
N0000175799,Dopamine D2 Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175799,,,,,,,Mechanism of Action
N0000000114,Dopamine Uptake Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000114,,,,,,,Mechanism of Action
N0000175732,Neuromuscular Nondepolarizing Blockade,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175732,,,,,,,Physiologic Effect
N0000175729,Central Nervous System Stimulation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175729,,,,,,,Physiologic Effect
N0000008779,Decreased Parasympathetic Acetylcholine Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008779,,,,,,,Physiologic Effect
N0000007618,Ergolines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007618,,,,,,,Chemical/Ingredient
N0000175654,Gonadotropin Releasing Hormone Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175654,,,,,,,Mechanism of Action
N0000167094,Benzothiazoles,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000167094,,,,,,,Chemical/Ingredient
N0000020024,Sclerosing Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020024,,,,,,,Mechanism of Action
N0000175379,Arteriolar Vasodilation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175379,,,,,,,Physiologic Effect
N0000175764,Serotonin 1d Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175764,,,,,,,Mechanism of Action
N0000175914,Increased Coagulation Factor VIII Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175914,,,,,,,Physiologic Effect
N0000007151,Folic Acid,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007151,,,,,,,Chemical/Ingredient
N0000008053,Sulfones,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008053,,,,,,,Chemical/Ingredient
N0000191267,Cytochrome P450 2D6 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191267,,,,,,,Mechanism of Action
N0000175089,Calcium Chelating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175089,,,,,,,Mechanism of Action
N0000008486,Decreased Central Nervous System Disorganized Electrical Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008486,,,,,,,Physiologic Effect
N0000008479,Decreased Cell Wall Synthesis & Repair,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008479,,,,,,,Physiologic Effect
N0000009947,Nucleoside Reverse Transcriptase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009947,,,,,,,Mechanism of Action
N0000009176,Increased Cellular Death,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009176,,,,,,,Physiologic Effect
N0000011281,Penicillins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011281,,,,,,,Chemical/Ingredient
N0000000070,Angiotensin 2 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000070,,,,,,,Mechanism of Action
N0000175087,Urease Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175087,,,,,,,Mechanism of Action
N0000185007,Adrenergic beta3-Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185007,,,,,,,Mechanism of Action
N0000000083,Leukotriene Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000083,,,,,,,Mechanism of Action
N0000191264,P-Glycoprotein Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191264,,,,,,,Mechanism of Action
N0000011414,Ketolides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011414,,,,,,,Chemical/Ingredient
N0000007647,Nitrates,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007647,,,,,,,Chemical/Ingredient
N0000187062,Cytochrome P450 2C8 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000187062,,,,,,,Mechanism of Action
N0000006277,Vitamin D,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006277,,,,,,,Chemical/Ingredient
N0000191272,UGT1A1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191272,,,,,,,Mechanism of Action
N0000175915,Increased Coagulation Factor VIII Concentration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175915,,,,,,,Physiologic Effect
N0000175960,Increased Glutathione Concentration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175960,,,,,,,Physiologic Effect
N0000008953,Decreased Striated Muscle Contraction,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008953,,,,,,,Physiologic Effect
N0000010262,Neurokinin 1 Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000010262,,,,,,,Mechanism of Action
N0000009282,Increased Dopamine Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009282,,,,,,,Physiologic Effect
N0000182138,Cytochrome P450 1A2 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182138,,,,,,,Mechanism of Action
N0000175359,Increased Diuresis,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175359,,,,,,,Physiologic Effect
N0000187063,Cytochrome P450 2C8 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000187063,,,,,,,Mechanism of Action
N0000175512,Methylated Sulfonamides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175512,,,,,,,Chemical/Ingredient
N0000190111,Organic Anion Transporter 3 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190111,,,,,,,Mechanism of Action
N0000006999,Urea,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006999,,,,,,,Chemical/Ingredient
N0000191265,Organic Cation Transporter 1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191265,,,,,,,Mechanism of Action
N0000000160,Cyclooxygenase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000160,,,,,,,Mechanism of Action
N0000000151,Histamine H2 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000151,,,,,,,Mechanism of Action
N0000007544,Phenothiazines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007544,,,,,,,Chemical/Ingredient
N0000009948,Non-Nucleoside Reverse Transcriptase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009948,,,,,,,Mechanism of Action
N0000007715,Catecholamines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007715,,,,,,,Chemical/Ingredient
N0000005760,Aminosalicylic Acids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000005760,,,,,,,Chemical/Ingredient
N0000175516,RNA Synthetase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175516,,,,,,,Mechanism of Action
N0000171207,Porphyrinogens,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000171207,,,,,,,Chemical/Ingredient
N0000008859,Decreased Renal K+ Excretion,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008859,,,,,,,Physiologic Effect
N0000009371,Increased Large Intestinal Motility,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009371,,,,,,,Physiologic Effect
N0000009963,Thrombin Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009963,,,,,,,Mechanism of Action
N0000000116,GABA B Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000116,,,,,,,Mechanism of Action
N0000008832,Decreased Platelet Aggregation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008832,,,,,,,Physiologic Effect
N0000007659,Nitrogen Mustard Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007659,,,,,,,Chemical/Ingredient
N0000000115,Progestational Hormone Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000115,,,,,,,Mechanism of Action
N0000008836,Decreased Prostaglandin Production,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008836,,,,,,,Physiologic Effect
N0000184306,Cell-mediated Immunity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000184306,,,,,,,Physiologic Effect
N0000010259,Ultrasound Contrast Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000010259,,,,,,,Mechanism of Action
N0000008683,Decreased Leukotriene Production,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008683,,,,,,,Physiologic Effect
N0000175830,Inhibit Ovum Fertilization,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175830,,,,,,,Physiologic Effect
N0000175080,Aromatase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175080,,,,,,,Mechanism of Action
N0000187064,Cytochrome P450 2B6 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000187064,,,,,,,Mechanism of Action
N0000175967,Thrombopoietin Receptor Interactions,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175967,,,,,,,Mechanism of Action
N0000000235,Carbonic Anhydrase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000235,,,,,,,Mechanism of Action
N0000006269,Vitamin A,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006269,,,,,,,Chemical/Ingredient
N0000007909,Psoralens,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007909,,,,,,,Chemical/Ingredient
N0000175921,Adrenal Steroid Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175921,,,,,,,Mechanism of Action
N0000007529,Macrolides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007529,,,,,,,Chemical/Ingredient
N0000006996,Cholecalciferol,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006996,,,,,,,Chemical/Ingredient
N0000009911,Venous Vasodilation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009911,,,,,,,Physiologic Effect
N0000185499,Guanylate Cyclase Activators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185499,,,,,,,Mechanism of Action
N0000000146,Androgen Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000146,,,,,,,Mechanism of Action
N0000006496,Nicotine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006496,,,,,,,Chemical/Ingredient
N0000175808,Hydroxyphenylpyruvate Dioxygenase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175808,,,,,,,Mechanism of Action
N0000175728,Central Nervous System Depression,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175728,,,,,,,Physiologic Effect
N0000007641,Nicotinic Acids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007641,,,,,,,Chemical/Ingredient
N0000007568,Oxazolidinones,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007568,,,,,,,Chemical/Ingredient
N0000175850,Melanin Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175850,,,,,,,Mechanism of Action
N0000190482,Phenylalanine Hydroxylase Activators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190482,,,,,,,Mechanism of Action
N0000170119,PPAR gamma,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000170119,,,,,,,Chemical/Ingredient
N0000009456,Increased Norepinephrine Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009456,,,,,,,Physiologic Effect
N0000000206,Xanthine Oxidase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000206,,,,,,,Mechanism of Action
N0000009871,Stimulation Large Intestine Fluid/Electrolyte Secretion,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009871,,,,,,,Physiologic Effect
N0000009724,Inhibition Gastric Acid Secretion,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009724,,,,,,,Physiologic Effect
N0000000183,Acetyl Aldehyde Dehydrogenase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000183,,,,,,,Mechanism of Action
N0000009269,Increased Cytokine Production,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009269,,,,,,,Physiologic Effect
N0000175073,Platinum-containing Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175073,,,,,,,Chemical/Ingredient
N0000000207,Histamine Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000207,,,,,,,Mechanism of Action
N0000175817,Serotonin 3 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175817,,,,,,,Mechanism of Action
N0000175635,Factor Xa Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175635,,,,,,,Mechanism of Action
N0000007822,Polymyxins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007822,,,,,,,Chemical/Ingredient
N0000007542,Benzodiazepines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007542,,,,,,,Chemical/Ingredient
N0000006801,Bile Acids and Salts,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006801,,,,,,,Chemical/Ingredient
N0000009801,Photosensitizing Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009801,,,,,,,Physiologic Effect
N0000000102,Norepinephrine Uptake Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000102,,,,,,,Mechanism of Action
N0000191280,Lipoglycopeptides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191280,,,,,,,Chemical/Ingredient
N0000009526,Increased Prostaglandin Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009526,,,,,,,Physiologic Effect
N0000011310,Aldosterone Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011310,,,,,,,Mechanism of Action
N0000000154,Opioid Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000154,,,,,,,Mechanism of Action
N0000007196,Iodine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007196,,,,,,,Chemical/Ingredient
N0000182137,Cytochrome P450 2D6 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182137,,,,,,,Mechanism of Action
N0000007522,Allylamine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007522,,,,,,,Chemical/Ingredient
N0000020081,Increased Calcium-sensing Receptor Sensitivity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020081,,,,,,,Mechanism of Action
N0000175755,DOPA Decarboxylase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175755,,,,,,,Mechanism of Action
N0000191274,UGT2B15 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191274,,,,,,,Mechanism of Action
N0000007780,Vinca Alkaloids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007780,,,,,,,Chemical/Ingredient
N0000175450,Corticosteroid Hormone Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175450,,,,,,,Mechanism of Action
N0000000150,Protein Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000150,,,,,,,Mechanism of Action
N0000175686,Competitive Opioid Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175686,,,,,,,Mechanism of Action
N0000000174,Opioid Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000174,,,,,,,Mechanism of Action
N0000006688,Carnitine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006688,,,,,,,Chemical/Ingredient
N0000175375,Peroxisome Proliferator-activated Receptor alpha Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175375,,,,,,,Mechanism of Action
N0000010217,Photoabsorption,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000010217,,,,,,,Mechanism of Action
N0000175788,Adenosine Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175788,,,,,,,Mechanism of Action
N0000175644,Decreased Autonomic Ganglionic Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175644,,,,,,,Physiologic Effect
N0000184148,Smoothened Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000184148,,,,,,,Mechanism of Action
N0000175763,Serotonin 1b Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175763,,,,,,,Mechanism of Action
N0000009905,Vascular Sclerosing Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009905,,,,,,,Physiologic Effect
N0000175075,Proteasome Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175075,,,,,,,Mechanism of Action
N0000007698,Biguanides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007698,,,,,,,Chemical/Ingredient
N0000009393,Increased Medullary Respiratory Drive,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009393,,,,,,,Physiologic Effect
N0000008016,Barbiturates,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008016,,,,,,,Chemical/Ingredient
N0000190109,Organic Anion Transporting Polypeptide 2B1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190109,,,,,,,Mechanism of Action
N0000000104,Cholinergic Muscarinic Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000104,,,,,,,Mechanism of Action
N0000008065,Purines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008065,,,,,,,Chemical/Ingredient
N0000180999,Angiotensin 2 Type 1 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000180999,,,,,,,Mechanism of Action
N0000175086,Phosphodiesterase 3 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175086,,,,,,,Mechanism of Action
N0000175970,Increased Platelet Production,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175970,,,,,,,Physiologic Effect
N0000191278,UGT1A9 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191278,,,,,,,Mechanism of Action
N0000009917,Adrenergic alpha1-Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009917,,,,,,,Mechanism of Action
N0000020026,Phosphodiesterase 5 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020026,,,,,,,Mechanism of Action
N0000175632,Decreased Fibrinolysis,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175632,,,,,,,Physiologic Effect
N0000184145,Chloride Channel Activation Potentiators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000184145,,,,,,,Mechanism of Action
N0000190118,Cytochrome P450 3A Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190118,,,,,,,Mechanism of Action
N0000020074,Phosphate Chelating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020074,,,,,,,Mechanism of Action
N0000008217,Azoles,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008217,,,,,,,Chemical/Ingredient
N0000175547,Reduction Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175547,,,,,,,Mechanism of Action
N0000175917,Thyroid Hormone Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175917,,,,,,,Mechanism of Action
N0000167510,"Estrogens, Conjugated (USP)",FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000167510,,,,,,,Chemical/Ingredient
N0000166743,Esters,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000166743,,,,,,,Chemical/Ingredient
N0000182960,Phosphodiesterase 4 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182960,,,,,,,Mechanism of Action
N0000175969,Increased Megakaryocyte Maturation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175969,,,,,,,Physiologic Effect
N0000175076,Protein Kinase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175076,,,,,,,Mechanism of Action
N0000186778,Microsomal Triglyceride Transfer Protein Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000186778,,,,,,,Mechanism of Action
N0000000166,alpha Glucosidase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000166,,,,,,,Mechanism of Action
N0000007961,"Heparin, Low-Molecular-Weight",FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007961,,,,,,,Chemical/Ingredient
N0000175513,Dipeptidase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175513,,,,,,,Mechanism of Action
N0000000191,Dihydrofolate Reductase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000191,,,,,,,Mechanism of Action
N0000185504,Cytochrome P450 2C9 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185504,,,,,,,Mechanism of Action
N0000007570,Pyridines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007570,,,,,,,Chemical/Ingredient
N0000175862,Magnetic Resonance Contrast Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175862,,,,,,,Mechanism of Action
N0000191258,RNA Replicase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191258,,,,,,,Mechanism of Action
N0000175459,Nucleoside Analog,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175459,,,,,,,Chemical/Ingredient
N0000178324,Increased Hematopoietic Stem Cell Mobilization,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000178324,,,,,,,Physiologic Effect
N0000011418,Streptogramins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011418,,,,,,,Chemical/Ingredient
N0000182140,Cytochrome P450 2C19 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182140,,,,,,,Mechanism of Action
N0000175370,Cholinergic Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175370,,,,,,,Mechanism of Action
N0000008553,Decreased Cholesterol Absorption,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008553,,,,,,,Physiologic Effect
N0000007620,Ergot Alkaloids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007620,,,,,,,Chemical/Ingredient
N0000007948,Tetracyclines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007948,,,,,,,Chemical/Ingredient
N0000000190,Histamine H1 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000190,,,,,,,Mechanism of Action
N0000008330,Cardiac Rhythm Alteration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008330,,,,,,,Physiologic Effect
N0000008054,Sulfonylurea Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008054,,,,,,,Chemical/Ingredient
N0000007770,Deoxyuridine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007770,,,,,,,Chemical/Ingredient
N0000000122,Adrenergic Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000122,,,,,,,Mechanism of Action
N0000000202,beta Lactamase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000202,,,,,,,Mechanism of Action
N0000007707,Diphosphonates,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007707,,,,,,,Chemical/Ingredient
N0000191423,Multidrug and Toxin Extrusion Transporter 1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191423,,,,,,,Mechanism of Action
N0000175965,Increased Prothrombin Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175965,,,,,,,Physiologic Effect
N0000009022,Digestive/GI System Activity Alteration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009022,,,,,,,Physiologic Effect
N0000007530,Anthracyclines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007530,,,,,,,Chemical/Ingredient
N0000006165,Triiodothyronine,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006165,,,,,,,Chemical/Ingredient
N0000008853,Decreased RNA Replication,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008853,,,,,,,Physiologic Effect
N0000175975,General Anesthesia,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175975,,,,,,,Physiologic Effect
N0000006014,Pyrethrins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006014,,,,,,,Chemical/Ingredient
N0000000069,Calcium Channel Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000069,,,,,,,Mechanism of Action
N0000008732,Decreased Mitosis,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008732,,,,,,,Physiologic Effect
N0000000168,Selective Estrogen Receptor Modulators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000168,,,,,,,Mechanism of Action
N0000009267,Increased Cytokine Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009267,,,,,,,Physiologic Effect
N0000006320,Vasopressins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006320,,,,,,,Chemical/Ingredient
N0000011311,Monobactams,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011311,,,,,,,Chemical/Ingredient
N0000187061,Organic Cation Transporter 2 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000187061,,,,,,,Mechanism of Action
N0000000209,Adrenergic alpha-Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000209,,,,,,,Mechanism of Action
N0000007621,Ergotamines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007621,,,,,,,Chemical/Ingredient
N0000175508,Lipopeptides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175508,,,,,,,Chemical/Ingredient
N0000175702,Partial Cholinergic Nicotinic Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175702,,,,,,,Mechanism of Action
N0000007681,Amides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007681,,,,,,,Chemical/Ingredient
N0000182728,Potassium Channel Openers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182728,,,,,,,Mechanism of Action
N0000000236,Alkylating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000236,,,,,,,Mechanism of Action
N0000182638,HCV NS3/4A Protease Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182638,,,,,,,Mechanism of Action
N0000007566,Benzylamines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007566,,,,,,,Chemical/Ingredient
N0000178478,Increased Blood Pressure,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000178478,,,,,,,Physiologic Effect
N0000009923,Adrenergic beta1-Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009923,,,,,,,Mechanism of Action
N0000170118,PPAR alpha,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000170118,,,,,,,Chemical/Ingredient
N0000007893,Glycosaminoglycans,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007893,,,,,,,Chemical/Ingredient
N0000175445,Chemokine Co-receptor 5 Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175445,,,,,,,Mechanism of Action
N0000175721,Nonsteroidal Anti-inflammatory Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175721,,,,,,,Chemical/Ingredient
N0000009945,Antidiuretic Hormone Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009945,,,,,,,Mechanism of Action
N0000007606,Quinolones,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007606,,,,,,,Chemical/Ingredient
N0000011402,Estradiol Congeners,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011402,,,,,,,Chemical/Ingredient
N0000166469,Thiazides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000166469,,,,,,,Chemical/Ingredient
N0000009048,GI Motility Alteration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009048,,,,,,,Physiologic Effect
N0000006290,Vitamin K,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006290,,,,,,,Chemical/Ingredient
N0000008157,Cardiac Glycosides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008157,,,,,,,Chemical/Ingredient
N0000191275,UGT1A3 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191275,,,,,,,Mechanism of Action
N0000175550,Decreased Immunologic Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175550,,,,,,,Physiologic Effect
N0000007663,Nitroimidazoles,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007663,,,,,,,Chemical/Ingredient
N0000011161,Cephalosporins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011161,,,,,,,Chemical/Ingredient
N0000175685,Partial Opioid Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175685,,,,,,,Mechanism of Action
N0000175372,Appetite Suppression,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175372,,,,,,,Physiologic Effect
N0000007889,Glycopeptides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007889,,,,,,,Chemical/Ingredient
N0000009982,Decreased Sebaceous Gland Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009982,,,,,,,Physiologic Effect
N0000008556,Decreased Coagulation Factor Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008556,,,,,,,Physiologic Effect
N0000175085,Microtubule Inhibition,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175085,,,,,,,Physiologic Effect
N0000000194,Somatostatin Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000194,,,,,,,Mechanism of Action
N0000190855,Vesicular Monoamine Transporter 2 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190855,,,,,,,Mechanism of Action
N0000009065,Hematologic Activity Alteration,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009065,,,,,,,Physiologic Effect
N0000184143,Carbamoyl Phosphate Synthetase 1 Activators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000184143,,,,,,,Mechanism of Action
N0000175733,Neuromuscular Depolarizing Blockade,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175733,,,,,,,Physiologic Effect
N0000175436,Neuraminidase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175436,,,,,,,Mechanism of Action
N0000191266,Cytochrome P450 1A2 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191266,,,,,,,Mechanism of Action
N0000007246,Estradiol,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007246,,,,,,,Chemical/Ingredient
N0000007706,Prostaglandins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007706,,,,,,,Chemical/Ingredient
N0000000196,GABA A Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000196,,,,,,,Mechanism of Action
N0000175542,M2 Protein Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175542,,,,,,,Mechanism of Action
N0000175624,mTOR Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175624,,,,,,,Mechanism of Action
N0000175955,5-Lipoxygenase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175955,,,,,,,Mechanism of Action
N0000182141,Cytochrome P450 3A4 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182141,,,,,,,Mechanism of Action
N0000190115,Cytochrome P450 3A5 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190115,,,,,,,Mechanism of Action
N0000175361,Catecholamine Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175361,,,,,,,Mechanism of Action
N0000175460,Non-Nucleoside Analog,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175460,,,,,,,Chemical/Ingredient
N0000010258,X-Ray Contrast Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000010258,,,,,,,Mechanism of Action
N0000007672,Polyenes,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007672,,,,,,,Chemical/Ingredient
N0000020000,Receptor Tyrosine Kinase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020000,,,,,,,Mechanism of Action
N0000175735,Decreased Striated Muscle Tone,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175735,,,,,,,Physiologic Effect
N0000007556,Dihydropyridines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007556,,,,,,,Chemical/Ingredient
N0000009034,Emesis Suppression,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009034,,,,,,,Physiologic Effect
N0000008663,Decreased Immunologically Active Molecule Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008663,,,,,,,Physiologic Effect
N0000175761,Monoamine Oxidase-B Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175761,,,,,,,Mechanism of Action
N0000190110,Organic Anion Transporter 1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190110,,,,,,,Mechanism of Action
N0000175084,Gonadotropin Releasing Hormone Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175084,,,,,,,Mechanism of Action
N0000009916,Lipase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009916,,,,,,,Mechanism of Action
N0000007683,Organometallic Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007683,,,,,,,Chemical/Ingredient
N0000175976,Local Anesthesia,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175976,,,,,,,Physiologic Effect
N0000175456,Chloride Channel Activators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175456,,,,,,,Mechanism of Action
N0000000111,Folic Acid Metabolism Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000111,,,,,,,Mechanism of Action
N0000009079,Increased Acetylcholine Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009079,,,,,,,Physiologic Effect
N0000185503,P-Glycoprotein Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185503,,,,,,,Mechanism of Action
N0000175964,Vitamin K Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175964,,,,,,,Mechanism of Action
N0000175982,Reversed Anticoagulation Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175982,,,,,,,Physiologic Effect
N0000175629,Increased Histamine Release,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175629,,,,,,,Physiologic Effect
N0000166489,Quaternary Ammonium Compounds,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000166489,,,,,,,Chemical/Ingredient
N0000191277,UGT1A6 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191277,,,,,,,Mechanism of Action
N0000007700,Retinoids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007700,,,,,,,Chemical/Ingredient
N0000009010,Decreased Tracheobronchial Stretch Receptor Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009010,,,,,,,Physiologic Effect
N0000190107,Organic Anion Transporting Polypeptide 1B1 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190107,,,,,,,Mechanism of Action
N0000000109,Serotonin Uptake Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000109,,,,,,,Mechanism of Action
N0000020060,DNA Polymerase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020060,,,,,,,Mechanism of Action
N0000009918,Adrenergic alpha2-Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009918,,,,,,,Mechanism of Action
N0000008867,Decreased Respiratory Secretion Viscosity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008867,,,,,,,Physiologic Effect
N0000020019,Glucosylceramide Synthase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020019,,,,,,,Mechanism of Action
N0000008118,Xanthines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008118,,,,,,,Chemical/Ingredient
N0000182147,Sigma-1 Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182147,,,,,,,Mechanism of Action
N0000000144,Iron Chelating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000144,,,,,,,Mechanism of Action
N0000008841,Decreased Protein Synthesis,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008841,,,,,,,Physiologic Effect
N0000006806,Amino Acids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006806,,,,,,,Chemical/Ingredient
N0000009059,Genitourinary Arterial Vasodilation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009059,,,,,,,Physiologic Effect
N0000175533,Dyes,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175533,,,,,,,Mechanism of Action
N0000175851,Depigmenting Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175851,,,,,,,Physiologic Effect
N0000185607,Cytochrome P450 2C19 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185607,,,,,,,Mechanism of Action
N0000175628,Decreased Histamine Release,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175628,,,,,,,Physiologic Effect
N0000175651,Increased Sympathetic Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175651,,,,,,,Physiologic Effect
N0000009922,Adrenergic beta2-Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009922,,,,,,,Mechanism of Action
N0000185507,Cytochrome P450 2C9 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185507,,,,,,,Mechanism of Action
N0000175650,Decreased Sympathetic Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175650,,,,,,,Physiologic Effect
N0000191269,UDP Glucuronosyltransferases Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191269,,,,,,,Mechanism of Action
N0000175472,Metal Chelating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175472,,,,,,,Mechanism of Action
N0000007911,Rifamycins,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007911,,,,,,,Chemical/Ingredient
N0000000125,Cholinergic Muscarinic Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000125,,,,,,,Mechanism of Action
N0000181815,Sphingosine 1-Phosphate Receptor Modulators,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000181815,,,,,,,Mechanism of Action
N0000007710,"Prostaglandins E, Synthetic",FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007710,,,,,,,Chemical/Ingredient
N0000191276,UGT1A4 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191276,,,,,,,Mechanism of Action
N0000175833,Acidifying Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175833,,,,,,,Mechanism of Action
N0000009924,Adrenergic beta2-Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009924,,,,,,,Mechanism of Action
N0000000243,Androgen Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000243,,,,,,,Mechanism of Action
N0000007983,Hydroxy Acids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007983,,,,,,,Chemical/Ingredient
N0000007883,Amphetamines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007883,,,,,,,Chemical/Ingredient
N0000175968,Thrombopoietin Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175968,,,,,,,Mechanism of Action
N0000175479,Amphenicols,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175479,,,,,,,Chemical/Ingredient
N0000006276,Vitamin B 12,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006276,,,,,,,Chemical/Ingredient
N0000175684,Full Opioid Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175684,,,,,,,Mechanism of Action
N0000191273,UGT2B7 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191273,,,,,,,Mechanism of Action
N0000171131,Allergens,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000171131,,,,,,,Chemical/Ingredient
N0000182143,P2Y12 Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182143,,,,,,,Mechanism of Action
N0000186774,Diarylquinolines,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000186774,,,,,,,Chemical/Ingredient
N0000007853,Aminoglycosides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007853,,,,,,,Chemical/Ingredient
N0000008478,Decreased Cell Wall Integrity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008478,,,,,,,Physiologic Effect
N0000000233,Nucleic Acid Synthesis Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000233,,,,,,,Mechanism of Action
N0000000239,P-Glycoprotein Interactions,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000239,,,,,,,Mechanism of Action
N0000000106,Prostaglandin Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000106,,,,,,,Mechanism of Action
N0000011294,Carbapenems,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011294,,,,,,,Chemical/Ingredient
N0000175442,Lincosamides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175442,,,,,,,Chemical/Ingredient
N0000000246,HIV Protease Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000246,,,,,,,Mechanism of Action
N0000181819,Uncompetitive NMDA Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000181819,,,,,,,Mechanism of Action
N0000175433,pleuromutilin,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175433,,,,,,,Chemical/Ingredient
N0000175549,Cystine Disulfide Reduction,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175549,,,,,,,Mechanism of Action
N0000191624,Cytochrome P450 1A Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000191624,,,,,,,Mechanism of Action
N0000005934,Progesterone,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000005934,,,,,,,Chemical/Ingredient
N0000175912,Dipeptidyl Peptidase 4 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175912,,,,,,,Mechanism of Action
N0000185506,Cytochrome P450 3A4 Inducers,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000185506,,,,,,,Mechanism of Action
N0000175448,Potassium Channel Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175448,,,,,,,Mechanism of Action
N0000187058,Sodium-Glucose Transporter 2 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000187058,,,,,,,Mechanism of Action
N0000008241,Androstanes,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008241,,,,,,,Chemical/Ingredient
N0000000176,Topoisomerase Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000176,,,,,,,Mechanism of Action
N0000007888,Bismuth,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007888,,,,,,,Chemical/Ingredient
N0000175374,Peroxisome Proliferator-activated Receptor Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175374,,,,,,,Mechanism of Action
N0000190113,Breast Cancer Resistance Protein Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190113,,,,,,,Mechanism of Action
N0000006337,Ergocalciferols,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000006337,,,,,,,Chemical/Ingredient
N0000175469,Pyrophosphate Analog,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175469,,,,,,,Chemical/Ingredient
N0000000250,Melatonin Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000250,,,,,,,Mechanism of Action
N0000175365,Bile-acid Binding Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175365,,,,,,,Mechanism of Action
N0000175730,Centrally-mediated Muscle Relaxation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175730,,,,,,,Physiologic Effect
N0000175366,Increased Diuresis at Loop of Henle,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175366,,,,,,,Physiologic Effect
N0000008010,Cannabinoids,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008010,,,,,,,Chemical/Ingredient
N0000007658,Nitrofurans,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000007658,,,,,,,Chemical/Ingredient
N0000020015,NMDA Receptor Antagonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000020015,,,,,,,Mechanism of Action
N0000009909,Vasodilation,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000009909,,,,,,,Physiologic Effect
N0000182139,Cytochrome P450 2B6 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000182139,,,,,,,Mechanism of Action
N0000175962,Lead Chelating Activity,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175962,,,,,,,Mechanism of Action
N0000011301,Progesterone Congeners,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011301,,,,,,,Chemical/Ingredient
N0000008638,Decreased GnRH Secretion,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008638,,,,,,,Physiologic Effect
N0000008048,Sulfonamides,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008048,,,,,,,Chemical/Ingredient
N0000190108,Organic Anion Transporting Polypeptide 1B3 Inhibitors,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000190108,,,,,,,Mechanism of Action
N0000000100,Estrogen Receptor Agonists,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000000100,,,,,,,Mechanism of Action
N0000008577,Decreased DNA Replication,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000008577,,,,,,,Physiologic Effect
N0000175972,Decreased Platelet Production,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000175972,,,,,,,Physiologic Effect
N0000011280,Prostaglandins I,FDA via DrugCentral,CC BY 4.0,http://purl.bioontology.org/ontology/NDFRT/N0000011280,,,,,,,Chemical/Ingredient
1 id name source license url description chromosome inchikey inchi mesh_id bto_id class_type
2 N0000007632 Thyroxine FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007632 Chemical/Ingredient
3 N0000011272 Thiazolidinediones FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000011272 Chemical/Ingredient
4 N0000178477 Decreased Blood Pressure FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000178477 Physiologic Effect
5 N0000010288 Osmotic Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000010288 Mechanism of Action
6 N0000190114 Cytochrome P450 3A Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000190114 Mechanism of Action
7 N0000175799 Dopamine D2 Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175799 Mechanism of Action
8 N0000000114 Dopamine Uptake Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000114 Mechanism of Action
9 N0000175732 Neuromuscular Nondepolarizing Blockade FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175732 Physiologic Effect
10 N0000175729 Central Nervous System Stimulation FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175729 Physiologic Effect
11 N0000008779 Decreased Parasympathetic Acetylcholine Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008779 Physiologic Effect
12 N0000007618 Ergolines FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007618 Chemical/Ingredient
13 N0000175654 Gonadotropin Releasing Hormone Receptor Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175654 Mechanism of Action
14 N0000167094 Benzothiazoles FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000167094 Chemical/Ingredient
15 N0000020024 Sclerosing Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000020024 Mechanism of Action
16 N0000175379 Arteriolar Vasodilation FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175379 Physiologic Effect
17 N0000175764 Serotonin 1d Receptor Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175764 Mechanism of Action
18 N0000175914 Increased Coagulation Factor VIII Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175914 Physiologic Effect
19 N0000007151 Folic Acid FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007151 Chemical/Ingredient
20 N0000008053 Sulfones FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008053 Chemical/Ingredient
21 N0000191267 Cytochrome P450 2D6 Inducers FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000191267 Mechanism of Action
22 N0000175089 Calcium Chelating Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175089 Mechanism of Action
23 N0000008486 Decreased Central Nervous System Disorganized Electrical Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008486 Physiologic Effect
24 N0000008479 Decreased Cell Wall Synthesis & Repair FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008479 Physiologic Effect
25 N0000009947 Nucleoside Reverse Transcriptase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009947 Mechanism of Action
26 N0000009176 Increased Cellular Death FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009176 Physiologic Effect
27 N0000011281 Penicillins FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000011281 Chemical/Ingredient
28 N0000000070 Angiotensin 2 Receptor Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000070 Mechanism of Action
29 N0000175087 Urease Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175087 Mechanism of Action
30 N0000185007 Adrenergic beta3-Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000185007 Mechanism of Action
31 N0000000083 Leukotriene Receptor Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000083 Mechanism of Action
32 N0000191264 P-Glycoprotein Inducers FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000191264 Mechanism of Action
33 N0000011414 Ketolides FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000011414 Chemical/Ingredient
34 N0000007647 Nitrates FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007647 Chemical/Ingredient
35 N0000187062 Cytochrome P450 2C8 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000187062 Mechanism of Action
36 N0000006277 Vitamin D FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000006277 Chemical/Ingredient
37 N0000191272 UGT1A1 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000191272 Mechanism of Action
38 N0000175915 Increased Coagulation Factor VIII Concentration FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175915 Physiologic Effect
39 N0000175960 Increased Glutathione Concentration FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175960 Physiologic Effect
40 N0000008953 Decreased Striated Muscle Contraction FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008953 Physiologic Effect
41 N0000010262 Neurokinin 1 Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000010262 Mechanism of Action
42 N0000009282 Increased Dopamine Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009282 Physiologic Effect
43 N0000182138 Cytochrome P450 1A2 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000182138 Mechanism of Action
44 N0000175359 Increased Diuresis FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175359 Physiologic Effect
45 N0000187063 Cytochrome P450 2C8 Inducers FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000187063 Mechanism of Action
46 N0000175512 Methylated Sulfonamides FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175512 Chemical/Ingredient
47 N0000190111 Organic Anion Transporter 3 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000190111 Mechanism of Action
48 N0000006999 Urea FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000006999 Chemical/Ingredient
49 N0000191265 Organic Cation Transporter 1 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000191265 Mechanism of Action
50 N0000000160 Cyclooxygenase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000160 Mechanism of Action
51 N0000000151 Histamine H2 Receptor Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000151 Mechanism of Action
52 N0000007544 Phenothiazines FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007544 Chemical/Ingredient
53 N0000009948 Non-Nucleoside Reverse Transcriptase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009948 Mechanism of Action
54 N0000007715 Catecholamines FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007715 Chemical/Ingredient
55 N0000005760 Aminosalicylic Acids FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000005760 Chemical/Ingredient
56 N0000175516 RNA Synthetase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175516 Mechanism of Action
57 N0000171207 Porphyrinogens FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000171207 Chemical/Ingredient
58 N0000008859 Decreased Renal K+ Excretion FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008859 Physiologic Effect
59 N0000009371 Increased Large Intestinal Motility FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009371 Physiologic Effect
60 N0000009963 Thrombin Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009963 Mechanism of Action
61 N0000000116 GABA B Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000116 Mechanism of Action
62 N0000008832 Decreased Platelet Aggregation FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008832 Physiologic Effect
63 N0000007659 Nitrogen Mustard Compounds FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007659 Chemical/Ingredient
64 N0000000115 Progestational Hormone Receptor Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000115 Mechanism of Action
65 N0000008836 Decreased Prostaglandin Production FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008836 Physiologic Effect
66 N0000184306 Cell-mediated Immunity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000184306 Physiologic Effect
67 N0000010259 Ultrasound Contrast Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000010259 Mechanism of Action
68 N0000008683 Decreased Leukotriene Production FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008683 Physiologic Effect
69 N0000175830 Inhibit Ovum Fertilization FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175830 Physiologic Effect
70 N0000175080 Aromatase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175080 Mechanism of Action
71 N0000187064 Cytochrome P450 2B6 Inducers FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000187064 Mechanism of Action
72 N0000175967 Thrombopoietin Receptor Interactions FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175967 Mechanism of Action
73 N0000000235 Carbonic Anhydrase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000235 Mechanism of Action
74 N0000006269 Vitamin A FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000006269 Chemical/Ingredient
75 N0000007909 Psoralens FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007909 Chemical/Ingredient
76 N0000175921 Adrenal Steroid Synthesis Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175921 Mechanism of Action
77 N0000007529 Macrolides FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007529 Chemical/Ingredient
78 N0000006996 Cholecalciferol FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000006996 Chemical/Ingredient
79 N0000009911 Venous Vasodilation FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009911 Physiologic Effect
80 N0000185499 Guanylate Cyclase Activators FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000185499 Mechanism of Action
81 N0000000146 Androgen Receptor Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000146 Mechanism of Action
82 N0000006496 Nicotine FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000006496 Chemical/Ingredient
83 N0000175808 Hydroxyphenylpyruvate Dioxygenase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175808 Mechanism of Action
84 N0000175728 Central Nervous System Depression FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175728 Physiologic Effect
85 N0000007641 Nicotinic Acids FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007641 Chemical/Ingredient
86 N0000007568 Oxazolidinones FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007568 Chemical/Ingredient
87 N0000175850 Melanin Synthesis Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175850 Mechanism of Action
88 N0000190482 Phenylalanine Hydroxylase Activators FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000190482 Mechanism of Action
89 N0000170119 PPAR gamma FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000170119 Chemical/Ingredient
90 N0000009456 Increased Norepinephrine Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009456 Physiologic Effect
91 N0000000206 Xanthine Oxidase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000206 Mechanism of Action
92 N0000009871 Stimulation Large Intestine Fluid/Electrolyte Secretion FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009871 Physiologic Effect
93 N0000009724 Inhibition Gastric Acid Secretion FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009724 Physiologic Effect
94 N0000000183 Acetyl Aldehyde Dehydrogenase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000183 Mechanism of Action
95 N0000009269 Increased Cytokine Production FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009269 Physiologic Effect
96 N0000175073 Platinum-containing Compounds FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175073 Chemical/Ingredient
97 N0000000207 Histamine Receptor Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000207 Mechanism of Action
98 N0000175817 Serotonin 3 Receptor Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175817 Mechanism of Action
99 N0000175635 Factor Xa Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175635 Mechanism of Action
100 N0000007822 Polymyxins FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007822 Chemical/Ingredient
101 N0000007542 Benzodiazepines FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007542 Chemical/Ingredient
102 N0000006801 Bile Acids and Salts FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000006801 Chemical/Ingredient
103 N0000009801 Photosensitizing Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009801 Physiologic Effect
104 N0000000102 Norepinephrine Uptake Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000102 Mechanism of Action
105 N0000191280 Lipoglycopeptides FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000191280 Chemical/Ingredient
106 N0000009526 Increased Prostaglandin Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009526 Physiologic Effect
107 N0000011310 Aldosterone Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000011310 Mechanism of Action
108 N0000000154 Opioid Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000154 Mechanism of Action
109 N0000007196 Iodine FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007196 Chemical/Ingredient
110 N0000182137 Cytochrome P450 2D6 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000182137 Mechanism of Action
111 N0000007522 Allylamine FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007522 Chemical/Ingredient
112 N0000020081 Increased Calcium-sensing Receptor Sensitivity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000020081 Mechanism of Action
113 N0000175755 DOPA Decarboxylase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175755 Mechanism of Action
114 N0000191274 UGT2B15 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000191274 Mechanism of Action
115 N0000007780 Vinca Alkaloids FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007780 Chemical/Ingredient
116 N0000175450 Corticosteroid Hormone Receptor Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175450 Mechanism of Action
117 N0000000150 Protein Synthesis Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000150 Mechanism of Action
118 N0000175686 Competitive Opioid Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175686 Mechanism of Action
119 N0000000174 Opioid Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000174 Mechanism of Action
120 N0000006688 Carnitine FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000006688 Chemical/Ingredient
121 N0000175375 Peroxisome Proliferator-activated Receptor alpha Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175375 Mechanism of Action
122 N0000010217 Photoabsorption FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000010217 Mechanism of Action
123 N0000175788 Adenosine Receptor Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175788 Mechanism of Action
124 N0000175644 Decreased Autonomic Ganglionic Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175644 Physiologic Effect
125 N0000184148 Smoothened Receptor Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000184148 Mechanism of Action
126 N0000175763 Serotonin 1b Receptor Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175763 Mechanism of Action
127 N0000009905 Vascular Sclerosing Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009905 Physiologic Effect
128 N0000175075 Proteasome Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175075 Mechanism of Action
129 N0000007698 Biguanides FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007698 Chemical/Ingredient
130 N0000009393 Increased Medullary Respiratory Drive FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009393 Physiologic Effect
131 N0000008016 Barbiturates FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008016 Chemical/Ingredient
132 N0000190109 Organic Anion Transporting Polypeptide 2B1 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000190109 Mechanism of Action
133 N0000000104 Cholinergic Muscarinic Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000104 Mechanism of Action
134 N0000008065 Purines FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008065 Chemical/Ingredient
135 N0000180999 Angiotensin 2 Type 1 Receptor Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000180999 Mechanism of Action
136 N0000175086 Phosphodiesterase 3 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175086 Mechanism of Action
137 N0000175970 Increased Platelet Production FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175970 Physiologic Effect
138 N0000191278 UGT1A9 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000191278 Mechanism of Action
139 N0000009917 Adrenergic alpha1-Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009917 Mechanism of Action
140 N0000020026 Phosphodiesterase 5 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000020026 Mechanism of Action
141 N0000175632 Decreased Fibrinolysis FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175632 Physiologic Effect
142 N0000184145 Chloride Channel Activation Potentiators FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000184145 Mechanism of Action
143 N0000190118 Cytochrome P450 3A Inducers FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000190118 Mechanism of Action
144 N0000020074 Phosphate Chelating Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000020074 Mechanism of Action
145 N0000008217 Azoles FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008217 Chemical/Ingredient
146 N0000175547 Reduction Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175547 Mechanism of Action
147 N0000175917 Thyroid Hormone Synthesis Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175917 Mechanism of Action
148 N0000167510 Estrogens, Conjugated (USP) FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000167510 Chemical/Ingredient
149 N0000166743 Esters FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000166743 Chemical/Ingredient
150 N0000182960 Phosphodiesterase 4 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000182960 Mechanism of Action
151 N0000175969 Increased Megakaryocyte Maturation FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175969 Physiologic Effect
152 N0000175076 Protein Kinase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175076 Mechanism of Action
153 N0000186778 Microsomal Triglyceride Transfer Protein Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000186778 Mechanism of Action
154 N0000000166 alpha Glucosidase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000166 Mechanism of Action
155 N0000007961 Heparin, Low-Molecular-Weight FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007961 Chemical/Ingredient
156 N0000175513 Dipeptidase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175513 Mechanism of Action
157 N0000000191 Dihydrofolate Reductase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000191 Mechanism of Action
158 N0000185504 Cytochrome P450 2C9 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000185504 Mechanism of Action
159 N0000007570 Pyridines FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007570 Chemical/Ingredient
160 N0000175862 Magnetic Resonance Contrast Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175862 Mechanism of Action
161 N0000191258 RNA Replicase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000191258 Mechanism of Action
162 N0000175459 Nucleoside Analog FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175459 Chemical/Ingredient
163 N0000178324 Increased Hematopoietic Stem Cell Mobilization FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000178324 Physiologic Effect
164 N0000011418 Streptogramins FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000011418 Chemical/Ingredient
165 N0000182140 Cytochrome P450 2C19 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000182140 Mechanism of Action
166 N0000175370 Cholinergic Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175370 Mechanism of Action
167 N0000008553 Decreased Cholesterol Absorption FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008553 Physiologic Effect
168 N0000007620 Ergot Alkaloids FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007620 Chemical/Ingredient
169 N0000007948 Tetracyclines FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007948 Chemical/Ingredient
170 N0000000190 Histamine H1 Receptor Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000190 Mechanism of Action
171 N0000008330 Cardiac Rhythm Alteration FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008330 Physiologic Effect
172 N0000008054 Sulfonylurea Compounds FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008054 Chemical/Ingredient
173 N0000007770 Deoxyuridine FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007770 Chemical/Ingredient
174 N0000000122 Adrenergic Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000122 Mechanism of Action
175 N0000000202 beta Lactamase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000202 Mechanism of Action
176 N0000007707 Diphosphonates FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007707 Chemical/Ingredient
177 N0000191423 Multidrug and Toxin Extrusion Transporter 1 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000191423 Mechanism of Action
178 N0000175965 Increased Prothrombin Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175965 Physiologic Effect
179 N0000009022 Digestive/GI System Activity Alteration FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009022 Physiologic Effect
180 N0000007530 Anthracyclines FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007530 Chemical/Ingredient
181 N0000006165 Triiodothyronine FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000006165 Chemical/Ingredient
182 N0000008853 Decreased RNA Replication FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008853 Physiologic Effect
183 N0000175975 General Anesthesia FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175975 Physiologic Effect
184 N0000006014 Pyrethrins FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000006014 Chemical/Ingredient
185 N0000000069 Calcium Channel Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000069 Mechanism of Action
186 N0000008732 Decreased Mitosis FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008732 Physiologic Effect
187 N0000000168 Selective Estrogen Receptor Modulators FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000168 Mechanism of Action
188 N0000009267 Increased Cytokine Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009267 Physiologic Effect
189 N0000006320 Vasopressins FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000006320 Chemical/Ingredient
190 N0000011311 Monobactams FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000011311 Chemical/Ingredient
191 N0000187061 Organic Cation Transporter 2 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000187061 Mechanism of Action
192 N0000000209 Adrenergic alpha-Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000209 Mechanism of Action
193 N0000007621 Ergotamines FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007621 Chemical/Ingredient
194 N0000175508 Lipopeptides FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175508 Chemical/Ingredient
195 N0000175702 Partial Cholinergic Nicotinic Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175702 Mechanism of Action
196 N0000007681 Amides FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007681 Chemical/Ingredient
197 N0000182728 Potassium Channel Openers FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000182728 Mechanism of Action
198 N0000000236 Alkylating Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000236 Mechanism of Action
199 N0000182638 HCV NS3/4A Protease Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000182638 Mechanism of Action
200 N0000007566 Benzylamines FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007566 Chemical/Ingredient
201 N0000178478 Increased Blood Pressure FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000178478 Physiologic Effect
202 N0000009923 Adrenergic beta1-Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009923 Mechanism of Action
203 N0000170118 PPAR alpha FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000170118 Chemical/Ingredient
204 N0000007893 Glycosaminoglycans FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007893 Chemical/Ingredient
205 N0000175445 Chemokine Co-receptor 5 Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175445 Mechanism of Action
206 N0000175721 Nonsteroidal Anti-inflammatory Compounds FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175721 Chemical/Ingredient
207 N0000009945 Antidiuretic Hormone Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009945 Mechanism of Action
208 N0000007606 Quinolones FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007606 Chemical/Ingredient
209 N0000011402 Estradiol Congeners FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000011402 Chemical/Ingredient
210 N0000166469 Thiazides FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000166469 Chemical/Ingredient
211 N0000009048 GI Motility Alteration FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009048 Physiologic Effect
212 N0000006290 Vitamin K FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000006290 Chemical/Ingredient
213 N0000008157 Cardiac Glycosides FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008157 Chemical/Ingredient
214 N0000191275 UGT1A3 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000191275 Mechanism of Action
215 N0000175550 Decreased Immunologic Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175550 Physiologic Effect
216 N0000007663 Nitroimidazoles FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007663 Chemical/Ingredient
217 N0000011161 Cephalosporins FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000011161 Chemical/Ingredient
218 N0000175685 Partial Opioid Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175685 Mechanism of Action
219 N0000175372 Appetite Suppression FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175372 Physiologic Effect
220 N0000007889 Glycopeptides FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007889 Chemical/Ingredient
221 N0000009982 Decreased Sebaceous Gland Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009982 Physiologic Effect
222 N0000008556 Decreased Coagulation Factor Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008556 Physiologic Effect
223 N0000175085 Microtubule Inhibition FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175085 Physiologic Effect
224 N0000000194 Somatostatin Receptor Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000194 Mechanism of Action
225 N0000190855 Vesicular Monoamine Transporter 2 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000190855 Mechanism of Action
226 N0000009065 Hematologic Activity Alteration FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009065 Physiologic Effect
227 N0000184143 Carbamoyl Phosphate Synthetase 1 Activators FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000184143 Mechanism of Action
228 N0000175733 Neuromuscular Depolarizing Blockade FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175733 Physiologic Effect
229 N0000175436 Neuraminidase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175436 Mechanism of Action
230 N0000191266 Cytochrome P450 1A2 Inducers FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000191266 Mechanism of Action
231 N0000007246 Estradiol FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007246 Chemical/Ingredient
232 N0000007706 Prostaglandins FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007706 Chemical/Ingredient
233 N0000000196 GABA A Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000196 Mechanism of Action
234 N0000175542 M2 Protein Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175542 Mechanism of Action
235 N0000175624 mTOR Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175624 Mechanism of Action
236 N0000175955 5-Lipoxygenase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175955 Mechanism of Action
237 N0000182141 Cytochrome P450 3A4 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000182141 Mechanism of Action
238 N0000190115 Cytochrome P450 3A5 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000190115 Mechanism of Action
239 N0000175361 Catecholamine Synthesis Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175361 Mechanism of Action
240 N0000175460 Non-Nucleoside Analog FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175460 Chemical/Ingredient
241 N0000010258 X-Ray Contrast Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000010258 Mechanism of Action
242 N0000007672 Polyenes FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007672 Chemical/Ingredient
243 N0000020000 Receptor Tyrosine Kinase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000020000 Mechanism of Action
244 N0000175735 Decreased Striated Muscle Tone FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175735 Physiologic Effect
245 N0000007556 Dihydropyridines FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007556 Chemical/Ingredient
246 N0000009034 Emesis Suppression FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009034 Physiologic Effect
247 N0000008663 Decreased Immunologically Active Molecule Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008663 Physiologic Effect
248 N0000175761 Monoamine Oxidase-B Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175761 Mechanism of Action
249 N0000190110 Organic Anion Transporter 1 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000190110 Mechanism of Action
250 N0000175084 Gonadotropin Releasing Hormone Receptor Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175084 Mechanism of Action
251 N0000009916 Lipase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009916 Mechanism of Action
252 N0000007683 Organometallic Compounds FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007683 Chemical/Ingredient
253 N0000175976 Local Anesthesia FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175976 Physiologic Effect
254 N0000175456 Chloride Channel Activators FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175456 Mechanism of Action
255 N0000000111 Folic Acid Metabolism Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000111 Mechanism of Action
256 N0000009079 Increased Acetylcholine Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009079 Physiologic Effect
257 N0000185503 P-Glycoprotein Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000185503 Mechanism of Action
258 N0000175964 Vitamin K Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175964 Mechanism of Action
259 N0000175982 Reversed Anticoagulation Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175982 Physiologic Effect
260 N0000175629 Increased Histamine Release FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175629 Physiologic Effect
261 N0000166489 Quaternary Ammonium Compounds FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000166489 Chemical/Ingredient
262 N0000191277 UGT1A6 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000191277 Mechanism of Action
263 N0000007700 Retinoids FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007700 Chemical/Ingredient
264 N0000009010 Decreased Tracheobronchial Stretch Receptor Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009010 Physiologic Effect
265 N0000190107 Organic Anion Transporting Polypeptide 1B1 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000190107 Mechanism of Action
266 N0000000109 Serotonin Uptake Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000109 Mechanism of Action
267 N0000020060 DNA Polymerase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000020060 Mechanism of Action
268 N0000009918 Adrenergic alpha2-Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009918 Mechanism of Action
269 N0000008867 Decreased Respiratory Secretion Viscosity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008867 Physiologic Effect
270 N0000020019 Glucosylceramide Synthase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000020019 Mechanism of Action
271 N0000008118 Xanthines FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008118 Chemical/Ingredient
272 N0000182147 Sigma-1 Receptor Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000182147 Mechanism of Action
273 N0000000144 Iron Chelating Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000144 Mechanism of Action
274 N0000008841 Decreased Protein Synthesis FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008841 Physiologic Effect
275 N0000006806 Amino Acids FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000006806 Chemical/Ingredient
276 N0000009059 Genitourinary Arterial Vasodilation FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009059 Physiologic Effect
277 N0000175533 Dyes FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175533 Mechanism of Action
278 N0000175851 Depigmenting Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175851 Physiologic Effect
279 N0000185607 Cytochrome P450 2C19 Inducers FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000185607 Mechanism of Action
280 N0000175628 Decreased Histamine Release FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175628 Physiologic Effect
281 N0000175651 Increased Sympathetic Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175651 Physiologic Effect
282 N0000009922 Adrenergic beta2-Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009922 Mechanism of Action
283 N0000185507 Cytochrome P450 2C9 Inducers FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000185507 Mechanism of Action
284 N0000175650 Decreased Sympathetic Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175650 Physiologic Effect
285 N0000191269 UDP Glucuronosyltransferases Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000191269 Mechanism of Action
286 N0000175472 Metal Chelating Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175472 Mechanism of Action
287 N0000007911 Rifamycins FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007911 Chemical/Ingredient
288 N0000000125 Cholinergic Muscarinic Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000125 Mechanism of Action
289 N0000181815 Sphingosine 1-Phosphate Receptor Modulators FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000181815 Mechanism of Action
290 N0000007710 Prostaglandins E, Synthetic FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007710 Chemical/Ingredient
291 N0000191276 UGT1A4 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000191276 Mechanism of Action
292 N0000175833 Acidifying Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175833 Mechanism of Action
293 N0000009924 Adrenergic beta2-Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009924 Mechanism of Action
294 N0000000243 Androgen Receptor Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000243 Mechanism of Action
295 N0000007983 Hydroxy Acids FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007983 Chemical/Ingredient
296 N0000007883 Amphetamines FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007883 Chemical/Ingredient
297 N0000175968 Thrombopoietin Receptor Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175968 Mechanism of Action
298 N0000175479 Amphenicols FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175479 Chemical/Ingredient
299 N0000006276 Vitamin B 12 FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000006276 Chemical/Ingredient
300 N0000175684 Full Opioid Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175684 Mechanism of Action
301 N0000191273 UGT2B7 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000191273 Mechanism of Action
302 N0000171131 Allergens FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000171131 Chemical/Ingredient
303 N0000182143 P2Y12 Receptor Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000182143 Mechanism of Action
304 N0000186774 Diarylquinolines FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000186774 Chemical/Ingredient
305 N0000007853 Aminoglycosides FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007853 Chemical/Ingredient
306 N0000008478 Decreased Cell Wall Integrity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008478 Physiologic Effect
307 N0000000233 Nucleic Acid Synthesis Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000233 Mechanism of Action
308 N0000000239 P-Glycoprotein Interactions FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000239 Mechanism of Action
309 N0000000106 Prostaglandin Receptor Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000106 Mechanism of Action
310 N0000011294 Carbapenems FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000011294 Chemical/Ingredient
311 N0000175442 Lincosamides FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175442 Chemical/Ingredient
312 N0000000246 HIV Protease Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000246 Mechanism of Action
313 N0000181819 Uncompetitive NMDA Receptor Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000181819 Mechanism of Action
314 N0000175433 pleuromutilin FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175433 Chemical/Ingredient
315 N0000175549 Cystine Disulfide Reduction FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175549 Mechanism of Action
316 N0000191624 Cytochrome P450 1A Inducers FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000191624 Mechanism of Action
317 N0000005934 Progesterone FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000005934 Chemical/Ingredient
318 N0000175912 Dipeptidyl Peptidase 4 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175912 Mechanism of Action
319 N0000185506 Cytochrome P450 3A4 Inducers FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000185506 Mechanism of Action
320 N0000175448 Potassium Channel Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175448 Mechanism of Action
321 N0000187058 Sodium-Glucose Transporter 2 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000187058 Mechanism of Action
322 N0000008241 Androstanes FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008241 Chemical/Ingredient
323 N0000000176 Topoisomerase Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000176 Mechanism of Action
324 N0000007888 Bismuth FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007888 Chemical/Ingredient
325 N0000175374 Peroxisome Proliferator-activated Receptor Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175374 Mechanism of Action
326 N0000190113 Breast Cancer Resistance Protein Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000190113 Mechanism of Action
327 N0000006337 Ergocalciferols FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000006337 Chemical/Ingredient
328 N0000175469 Pyrophosphate Analog FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175469 Chemical/Ingredient
329 N0000000250 Melatonin Receptor Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000250 Mechanism of Action
330 N0000175365 Bile-acid Binding Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175365 Mechanism of Action
331 N0000175730 Centrally-mediated Muscle Relaxation FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175730 Physiologic Effect
332 N0000175366 Increased Diuresis at Loop of Henle FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175366 Physiologic Effect
333 N0000008010 Cannabinoids FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008010 Chemical/Ingredient
334 N0000007658 Nitrofurans FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000007658 Chemical/Ingredient
335 N0000020015 NMDA Receptor Antagonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000020015 Mechanism of Action
336 N0000009909 Vasodilation FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000009909 Physiologic Effect
337 N0000182139 Cytochrome P450 2B6 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000182139 Mechanism of Action
338 N0000175962 Lead Chelating Activity FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175962 Mechanism of Action
339 N0000011301 Progesterone Congeners FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000011301 Chemical/Ingredient
340 N0000008638 Decreased GnRH Secretion FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008638 Physiologic Effect
341 N0000008048 Sulfonamides FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008048 Chemical/Ingredient
342 N0000190108 Organic Anion Transporting Polypeptide 1B3 Inhibitors FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000190108 Mechanism of Action
343 N0000000100 Estrogen Receptor Agonists FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000000100 Mechanism of Action
344 N0000008577 Decreased DNA Replication FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000008577 Physiologic Effect
345 N0000175972 Decreased Platelet Production FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000175972 Physiologic Effect
346 N0000011280 Prostaglandins I FDA via DrugCentral CC BY 4.0 http://purl.bioontology.org/ontology/NDFRT/N0000011280 Chemical/Ingredient